Conformis, Inc.
CFMS
Price:
$2.27
Market Cap:
$17.88M
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instr...[Read more]
Industry
Medical - Devices
IPO Date
2015-07-01
Stock Exchange
NASDAQ
Ticker
CFMS
The ROE as of September 2024 (TTM) for Conformis, Inc. (CFMS) is -86.46%
According to Conformis, Inc.’s latest financial reports and current stock price. The company's current ROE is -86.46%. This represents a change of 268.75% compared to the average of -23.45% of the last 4 quarters.
Conformis, Inc. (CFMS) Historical ROE (quarterly & annually)
How has CFMS ROE performed in the past?
The mean historical ROE of Conformis, Inc. over the last ten years is -98.14%. The current -86.46% ROE has changed -11.90% with respect to the historical average. Over the past ten years (40 quarters), CFMS's ROE was at its highest in in the June 2021 quarter at 30.26%. The ROE was at its lowest in in the March 2020 quarter at -98.31%.
Average
-98.14%
Median
-92.46%
Minimum
-213.64%
Maximum
-2.40%
Conformis, Inc. (CFMS) ROE by Quarter and Year
Discovering the peaks and valleys of Conformis, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.78%
Maximum Annual ROE = -2.40%
Minimum Annual Increase = -98.88%
Minimum Annual ROE = -213.64%
| Year | ROE | Change |
|---|---|---|
| 2022 | -93.16% | 3.78% |
| 2021 | -2.40% | -98.88% |
| 2020 | -213.64% | 22.63% |
| 2019 | -174.22% | 45.43% |
| 2018 | -119.80% | 4.00% |
| 2017 | -115.19% | 88.13% |
| 2016 | -61.23% | 51.04% |
| 2015 | -40.54% | -55.82% |
| 2014 | -91.76% | 32.14% |
Conformis, Inc. (CFMS) Average ROE
How has CFMS ROE performed in the past?
The current ROE of Conformis, Inc. (CFMS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-103.07%
5-year avg
-120.64%
10-year avg
-98.14%
Conformis, Inc. (CFMS) ROE vs. Peers
How is CFMS’s ROE compared to its peers?
Conformis, Inc.’s ROE is greater than Bone Biologics Corporation (-154.16%), greater than Tivic Health Systems, Inc. (-172.08%), greater than Bluejay Diagnostics, Inc. (-187.00%), greater than Vivos Therapeutics, Inc. (-652.32%), greater than Rapid Micro Biosystems, Inc. (-45.23%), greater than Artivion, Inc. (-2.92%), greater than Anika Therapeutics, Inc. (-32.91%), greater than Sight Sciences, Inc. (-45.68%), greater than Orthofix Medical Inc. (-20.68%), less than Avanos Medical, Inc. (0.63%), greater than CVRx, Inc. (-77.62%), less than Accelerate Diagnostics, Inc. (131.18%), greater than NeuroPace, Inc. (-195.26%), greater than AxoGen, Inc. (-17.30%), greater than Talis Biomedical Corporation (-79.73%), greater than Nuwellis, Inc. (-1671.56%), greater than Heart Test Laboratories, Inc. (-138.32%), less than PAVmed Inc. (96.45%), less than ProSomnus, Inc. Common Stock (50.75%), greater than Hyperfine, Inc. (-51.71%), greater than OrthoPediatrics Corp. (-6.73%),
| Company | ROE | Market cap |
|---|---|---|
| -154.16% | $2.94M | |
| -172.08% | $1.68M | |
| -187.00% | $2.50M | |
| -652.32% | $10.12M | |
| -45.23% | $36.48M | |
| -2.92% | $1.06B | |
| -32.91% | $367.11M | |
| -45.68% | $343.10M | |
| -20.68% | $632.17M | |
| 0.63% | $1.11B | |
| -77.62% | $164.48M | |
| 131.18% | $35.76M | |
| -195.26% | $203.07M | |
| -17.30% | $632.46M | |
| -79.73% | $3.10M | |
| -1671.56% | $2.58M | |
| -138.32% | $2.83M | |
| 96.45% | $18.47M | |
| 50.75% | $8.18M | |
| -51.71% | $76.25M | |
| -6.73% | $762.27M |
Build a custom stock screener for Conformis, Inc. (CFMS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Conformis, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Conformis, Inc. (CFMS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Conformis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Conformis, Inc.'s ROE?
How is the ROE calculated for Conformis, Inc. (CFMS)?
What is the highest ROE for Conformis, Inc. (CFMS)?
What is the 3-year average ROE for Conformis, Inc. (CFMS)?
What is the 5-year average ROE for Conformis, Inc. (CFMS)?
How does the current ROE for Conformis, Inc. (CFMS) compare to its historical average?